Search

Your search keyword '"Intravitreal Injections methods"' showing total 204 results

Search Constraints

Start Over You searched for: Descriptor "Intravitreal Injections methods" Remove constraint Descriptor: "Intravitreal Injections methods" Database MEDLINE Remove constraint Database: MEDLINE
204 results on '"Intravitreal Injections methods"'

Search Results

1. Development of puerarin-loaded poly(lactic acid) microspheres for sustained ocular delivery: In vitro/vivo evaluation.

2. Exosome-loaded degradable polymeric microcapsules for the treatment of vitreoretinal diseases.

4. Treatment Effects of Switching to Faricimab in Eyes with Diabetic Macular Edema Refractory to Aflibercept.

5. A prospective multicentre study of intravitreal injections and ocular surface in 219 patients: IVIS study.

6. Pathologic Correlation with Renal Dysfunction after Intravitreal Injections of Vascular Endothelial Growth Factor Antagonists.

7. Ocular Trauma Caused by Confetti Cannons.

8. Intraocular pressure and injection forces during intravitreal injection into enucleated porcine eyes.

9. Modifications of intravitreal injections in response to the COVID-19 pandemic.

10. Intravitreal injection of anti-miRs against miR-142-3p reduces angiogenesis and microglia activation in a mouse model of laser-induced choroidal neovascularization.

11. SELF-DESIGNATION OF THE TREATED EYE BEFORE INTRAVITREAL INJECTIONS: Prevalence and Predictors of Incorrect Calling.

12. Baseline characteristics of myopic choroidal neovascularization in patients above 50 years old and prognostic factors after intravitreal conbercept treatment.

13. Adrenomedullin-Receptor Activity-Modifying Protein 2 System Ameliorates Subretinal Fibrosis by Suppressing Epithelial-Mesenchymal Transition in Age-Related Macular Degeneration.

14. Container Closure and Delivery Considerations for Intravitreal Drug Administration.

15. Exosome-mediated delivery of an anti-angiogenic peptide inhibits pathological retinal angiogenesis.

16. Relationship between metamorphopsia and inner retinal microstructure following intravitreal ranibizumab injection for branch retinal vein occlusion.

17. Intravitreal conbercept improves outcome of proliferative diabetic retinopathy through inhibiting inflammation and oxidative stress.

18. Critical analysis of techniques and materials used in devices, syringes, and needles used for intravitreal injections.

19. Injectable in-situ gel depot system for targeted delivery of biologics to the retina.

20. Minocycline reduces inflammatory response and cell death in a S100B retina degeneration model.

21. Overexpression of miR-181a-5p inhibits retinal neovascularization through endocan and the ERK1/2 signaling pathway.

22. Penetration, distribution, and elimination of remofuscin/soraprazan in Stargardt mouse eyes following a single intravitreal injection using pharmacokinetics and transmission electron microscopic autoradiography: Implication for the local treatment of Stargardt's disease and dry age-related macular degeneration.

23. A sustained dual drug delivery system for proliferative vitreoretinopathy.

24. Assessment of Online Sites Reliability, Accountability, Readability, Accessibility, and Translation for Intravitreal Injections.

25. Six and eight weeks injection frequencies of bevacizumab are non-inferior to the current four weeks injection frequency for quality of life in neovascular age-related macular degeneration: a randomized controlled trial.

26. Intravitreous delivery of melatonin affects the retinal neuron survival and visual signal transmission: in vivo and ex vivo study.

27. Changes in Aqueous Cytokine Levels Following Intravitreal Aflibercept in Treatment-Naive Patients with Diabetic Macular Edema.

28. Decreased Periodicity of Reactivation Interval in Neovascular Age-Related Macular Degeneration in Patients with a Late First Reactivation After Initial Treatment.

29. Extended Pharmacokinetic Model of the Intravitreal Injections of Macromolecules in Rabbits. Part 2: Parameter Estimation Based on Concentration Dynamics in the Vitreous, Retina, and Aqueous Humor.

30. Vitreomacular traction quantitative cutoffs for the assessment of resolution after ocriplasmin intravitreal treatment.

31. Randomized Safety and Feasibility Trial of Ultra-Rapid Cooling Anesthesia for Intravitreal Injections.

32. Protocol for In Vivo Evaluation and Use of Destabilizing Domains in the Eye, Liver, and Beyond.

33. Role of Formulation Parameters on Intravitreal Dosing Accuracy Using 1 mL Hypodermic Syringes.

34. PET study of ocular and blood pharmacokinetics of intravitreal bevacizumab and aflibercept in rats.

35. Preclinical challenges for developing long acting intravitreal medicines.

36. Alcohol Pads and Nonsterile Gloves in Preparation of Aflibercept.

37. Intravitreal Pharmacokinetic Study of the Antiangiogenic Glycoprotein Opticin.

38. Suprachoroidal Delivery of Viral and Nonviral Gene Therapy for Retinal Diseases.

39. Current safety preferences for intravitreal injection during COVID-19 pandemic.

40. Evaluation of Microvascular Structure Changes after Conbercept Treatment on Macular Edema Secondary to Retinal Vein Occlusion.

41. Group II metabotropic glutamate receptor agonist promotes retinal ganglion cell survival by reducing neuronal excitotoxicity in a rat chronic ocular hypertension model.

42. Apigenin Regulates Activation of Microglia and Counteracts Retinal Degeneration.

43. [How to approach intravitreal injections during this COVID-19 pandemic ?]

44. Contribution of platelet-derived growth factor signaling to retina regeneration in zebrafish.

45. Customized disposable kit versus a conventional stainless steel instrument for an intravitreal injection: A comparison.

46. Refractory adult Coats disease treated with dexamethasone intravitreal implant: A case report.

47. Contralateral effect of systemic absorption of low dose bevacizumab (Avastin) after unilateral intravitreal injection in severe retinopathy of prematurity (ROP).

48. Intravitreal anti-VEGF agents and cardiovascular risk.

49. Ocular Half-Life of Intravitreal Biologics in Humans and Other Species: Meta-Analysis and Model-Based Prediction.

50. Release of silicone oil and the off-label use of syringes in ophthalmology.

Catalog

Books, media, physical & digital resources